Breast Cancer Panel - Disclosures
|
Panel Member
|
Jame Abraham MD, FACP |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Vandana Abramson MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Rebecca Aft MD, PhD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Doreen Agnese MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Kimberly Allison MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Bethany Anderson MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Janet Bailey MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Marian Birkeland PhD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Nicole Blankenhorn |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Harold Burstein MD, PhD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Nan Chen MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Helen Chew MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Chau Dang MD |
|
Grant/Research Support
|
| Daiichi- Sankyo Co. | Roche/Genentech |
|
Date Completed
|
03/24/2025 |
|
Panel Member
|
Sarah DeVincenzo PharmD, BCPS |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Anthony Elias MD |
|
Grant/Research Support
|
| C4 Therapeutics | Scorpion |
|
Date Completed
|
06/18/2024 |
|
Panel Member
|
Tanya Fischer MEd, MLIS |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Sharon Giordano MD, MPH |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Matthew Goetz MD |
|
Equity Interest/Stock Options
|
| SimBioSys |
|
Grant/Research Support
|
| AstraZeneca Pharmaceuticals LP | Atossa | Biotheryx | Eli Lilly and Company | Pfizer Inc. | sermonix pharmaceuticals | SimBioSys |
|
Date Completed
|
12/31/2024 |
|
Panel Member
|
William Gradishar MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Kristina Gregory MSN, RN |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Evelyn Handel PharmD, BCOP, BCPS |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Kyle Herrmann BSN, RN, OCN |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Erin Hesler |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Rachel Jankowitz MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Sara Javid MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Rashmi Kumar PhD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
A. Marilyn Leitch MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Janice Lyons MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Susie McCloskey MD, MSHS |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Melissa McShane MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Meena Moran MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Svitlana Ostanina PhD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Sameer Patel MD, FACS |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Donna Powell DHSc, CMD, RT(T) |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Laura Rosenberger MD, MS |
|
Grant/Research Support
|
| Natera |
|
Date Completed
|
07/29/2024 |
|
Panel Member
|
Hope Rugo MD |
|
Grant/Research Support
|
| Ambryx | AstraZeneca Pharmaceuticals LP | Daiichi- Sankyo Co. | F. Hoffmann-La Roche AG/Genentech, Inc | Gilead Sciences, Inc. | Lilly | Merck & Co., Inc. | Novartis Pharmaceuticals Corporation | OBI Pharma | Pfizer Inc. | Stemline Therapeutics |
|
Date Completed
|
12/09/2024 |
|
Panel Member
|
Cesar Santa-Maria MD, MSCI |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Bryan Schneider MD |
|
Grant/Research Support
|
| Foundation Medicine | Genentech, Inc. | Pfizer Inc. |
|
Date Completed
|
09/14/2024 |
|
Panel Member
|
Ryan Schonfeld BA |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Mary Lou Smith MBA, JD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Hatem Soliman MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Erica Stringer-Reasor MD |
|
Grant/Research Support
|
| GSK | Regeneron Pharmactcls | TESARO, Inc. |
|
Date Completed
|
08/22/2024 |
|
Panel Member
|
Melinda Telli MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Mei Wei MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Kari Wisinski MD |
|
Grant/Research Support
|
| Alterome | AstraZeneca Pharmaceuticals LP | Genentech, Inc. | Gilead Sciences, Inc. | Jazz Pharmaceuticals | Loxo@Lilly | Novartis Pharmaceuticals Corporation | Pfizer Inc. | Puma Biotechnology | Relay Therapeutics | Roche Laboratories, Inc. |
|
Date Completed
|
05/12/2025 |
|
Panel Member
|
Amulya Yellala MBBS |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Kay Yeung MD, PhD |
|
Grant/Research Support
|
| Arvinas | AstraZeneca Pharmaceuticals LP | Biofluidica | Dantari | Gilead Sciences, Inc. | Jazz Pharmaceuticals Inc. | Pfizer Inc. | Relay Therapeutics | SeaGen | Treadwell Therapeutics |
|
Date Completed
|
10/18/2024 |
|
Panel Member
|
Jessica Young MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
